Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of most bothersome symptom (MBS) associated with migraine using anti-CGRP antibodies

Treatment of most bothersome symptom (MBS) associated with migraine using anti-CGRP antibodies

US Patent 12384837 · Granted Aug 12, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Humanized anti-ACTH antibodies and use thereof2025
Acute treatment and rapid treatment of headache using anti-CGRP antibodies2025
Acute treatment and rapid treatment of headache using anti-CGRP antibodies2025
Acute treatment and rapid treatment of headache using anti-CGRP antibodies2025
Treatment of headache using anti-CGRP antibodies2025
Treatment of headache using anti-CGRP antibodies2025
Treatment of headache using anti-CGRP antibodies2025
Anti-ACTH antibodies and use thereof2025
Acute treatment and rapid treatment of headache using anti-CGRP antibodies2025
Acute treatment and rapid treatment of headache using anti-CGRP antibodies2025
Acute treatment and rapid treatment of headache using anti-CGRP antibodies2025
Treatment of headache using anti-CGRP antibodies2025